Loading...
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study()
There is currently an outbreak of respiratory disease caused by a novel coronavirus. The virus has been named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease it causes has been named coronavirus disease 2019 (COVID-19). More than 16% of patients developed acute respirato...
Na minha lista:
| Udgivet i: | Engineering (Beijing) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
THE AUTHORS. Published by Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7185795/ https://ncbi.nlm.nih.gov/pubmed/32346491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eng.2020.03.007 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|